No definition available.
Generalized skin eruption due to drugs and medicaments
GENERALI_SKIN_ERUPT_DRUGS_MEDICAM
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1540 |
4. Check minimum number of eventsNone |
1540 |
5. Include endpointsNone |
1540 |
6. Filter based on genotype QC (FinnGen only) |
1502 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Generalized skin eruption due to drugs and medicaments
based on the number of shared cases.
Similar with more cases:
- Acute generalized exanthematous pustulosis
- Dermatitis due to substances taken internally
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11054 | 6550 | 4445 |
| Only index persons | 9672 | 5844 | 3828 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.19 | 0.12 |
| Only index persons | 0.19 | 0.21 | 0.15 |
| Median age at first event (years) | |||
| Whole population | 49.28 | 52.61 | 44.11 |
| Only index persons | 48.96 | 51.80 | 44.62 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1502 | 977 | 525 |
| Unadjusted period prevalence (%) | 0.31 | 0.35 | 0.24 |
| Median age at first event (years) | 56.07 | 52.89 | 61.97 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1540
- Matched controls
- 15400
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4503599627370496.0
307.7
1537
24
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.3
192.6
385
769
H02AB06
ATC
prednisolone; systemic
4.0
146.3
1041
5267
XQ820
NOMESCO Finland
Exposure to medicinal substance
54.7
128.1
73
14
XQ800
NOMESCO Finland
Prick test
5.2
116.3
272
611
L50.0
ICD-10 Finland
Allergic urticaria
8.7
107.2
142
178
XQ899
NOMESCO Finland
Other assessment of skin
30.5
105.9
70
24
XQ802
NOMESCO Finland
Epicutan test
6.7
104.3
177
293
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
84.2
266
748
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
81.6
466
1908
R06AE07
ATC
cetirizine; oral
2.7
80.7
884
5078
T78.4
ICD-10 Finland
Allergy, unspecified
5.5
79.2
164
327
J01FF01
ATC
clindamycin; systemic
2.8
77.2
570
2669
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.6
77.2
101
124
XQ801
NOMESCO Finland
Intracutantest
19.0
69.3
55
30
D07AC01
ATC
betamethasone; topical
2.5
66.8
685
3711
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
66.8
830
4911
D07AB08
ATC
desonide; topical
3.4
66.6
281
951
E0000UV, ,
ATC
2.5
66.5
813
4772
R50.9
ICD-10 Finland
Fever, unspecified
3.0
66.5
360
1412
L50.9
ICD-10 Finland
Urticaria, unspecified
5.4
62.5
131
263
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
9.4
62.4
76
85
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
57.6
249
851
J01MA12
ATC
levofloxacin; systemic
2.6
49.5
358
1610
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.2
44.8
124
312
D07AA02
ATC
hydrocortisone; topical
2.6
44.0
313
1388
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
13.1
43.6
42
33
D07AB02
ATC
hydrocortisone butyrate; topical
2.2
41.6
539
3084
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
41.4
587
3475
ZX108
NOMESCO Finland
Inhalation
12.4
41.2
41
34
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
40.9
272
1165
A46
ICD-10 Finland
Erysipelas
2.6
40.1
266
1137
E000001, ,
ATC
2.3
39.7
399
2056
TQW80
NOMESCO Finland
Local dermatologic skincare
5.3
39.0
80
157
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
38.5
231
938
C01CA24
ATC
epinephrine; parenteral
3.2
38.0
164
555
P01BA02
ATC
hydroxychloroquine; oral
3.0
36.9
179
648
L04AX01
ATC
azathioprine; systemic
3.9
36.1
110
296
L04AX03
ATC
methotrexate; systemic
2.8
35.1
201
795
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
13.6
34.0
32
24
L04AD01
ATC
ciclosporin; systemic
5.9
34.0
62
109
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
32.7
382
2069
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.7
32.7
107
303
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
30.9
414
2353
N03AG01
ATC
valproic acid; systemic, rectal
3.2
30.7
132
444
A02BC02
ATC
pantoprazole; systemic
1.9
30.1
1045
8074
J01MA14
ATC
moxifloxacin; systemic
2.7
29.8
171
675
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
29.8
110
337
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
29.7
475
2866
J01MA02
ATC
ciprofloxacin; systemic
1.9
29.6
606
3965
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
29.1
105
317
JN4AD
NOMESCO Finland
Body CT examination
2.6
28.9
182
752
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
28.3
207
919
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
27.6
111
359
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.9
27.0
82
220
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.8
26.6
60
128
H02AB04
ATC
methylprednisolone; systemic
2.2
26.4
252
1252
D07AC13
ATC
mometasone; topical
1.9
26.1
474
2960
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
26.1
265
1349
D07AD01
ATC
clobetasol; topical
2.1
26.0
281
1465
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.7
25.7
146
572
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
25.7
376
2186
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
24.9
136
522
J01XX08
ATC
linezolid; systemic
10.2
24.8
28
28
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.5
24.6
86
254
N02AA05
ATC
oxycodone; systemic
2.1
24.6
289
1553
ZX120
NOMESCO Finland
Intravenous
2.4
24.5
180
798
L04AA06
ATC
mycophenolic acid; systemic
5.0
24.5
53
109
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.1
24.5
68
171
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
24.3
276
1464
J01DB01
ATC
cefalexin; oral
2.0
24.1
1278
10869
L27.2
ICD-10 Finland
Dermatitis due to ingested food
6.1
23.9
42
71
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
23.6
364
2147
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
23.1
194
911
H02AB07
ATC
prednisone; oral
2.1
23.1
238
1215
A04AA01
ATC
ondansetron; systemic, rectal
2.5
22.7
154
658
H02AB02
ATC
dexamethasone; systemic
2.2
22.7
200
959
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
22.7
86
268
N02AX02
ATC
tramadol; systemic, rectal
1.7
22.6
639
4503
C03CA01
ATC
furosemide; systemic
1.8
22.0
442
2821
E000006, ,
ATC
2.6
21.4
134
551
L50.8
ICD-10 Finland
Other urticaria
4.6
21.4
51
114
M04AA01
ATC
allopurinol; systemic
2.2
21.3
200
982
N03AX16
ATC
[U] pregabalin
1.8
21.1
361
2190
E000003, ,
ATC
3.0
20.6
94
327
H02AB09
ATC
hydrocortisone; systemic
4.0
20.6
59
152
JN4BD
NOMESCO Finland
Extensive body CT
2.3
20.4
170
794
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
20.4
127
520
N03AX14
ATC
levetiracetam; systemic
3.8
20.3
62
167
D02AX
ATC
Other emollients and protectives
3.4
20.3
74
225
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.6
20.3
128
528
XQ848
NOMESCO Finland
Dermatological photography
3.8
20.3
63
172
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.6
20.2
48
107
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
20.0
351
2144
L01BA01
ATC
methotrexate; systemic
3.3
19.9
77
243
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.6
19.6
121
494
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
19.6
222
1171
J01DA01
ATC
[U] cefalexin
1.6
19.2
930
7414
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
19.0
159
744
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
19.0
156
725
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
18.5
164
786
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.0
18.3
85
299
R06AX27
ATC
desloratadine; oral
1.7
18.2
460
3104
N03AF02
ATC
oxcarbazepine; oral
3.3
18.1
70
221
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.8
18.1
55
148
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
17.9
175
872
N03AF01
ATC
carbamazepine; oral, rectal
2.7
17.8
98
377
N03AX09
ATC
lamotrigine; oral
2.7
17.6
96
368
SPAT1255
SPAT
Intravenous administration of medicine
2.5
17.5
111
458
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
17.5
136
616
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.1
17.4
48
120
E000002, ,
ATC
2.0
17.3
194
1016
D07XC01
ATC
betamethasone; topical
2.1
17.3
186
960
J05AB11
ATC
valaciclovir; oral
1.9
17.3
237
1332
A92
ICPC
Allergy/allergic reaction NOS
3.3
17.2
67
212
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
17.2
556
3982
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.8
17.2
53
144
S88
ICPC
Dermatitis contact/allergic
3.9
17.1
50
131
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
6.7
17.1
27
41
NF1AA
NOMESCO Finland
Hip X-ray examination
2.2
17.0
146
690
WW500
NOMESCO Finland
Blood transfusion
2.9
17.0
81
289
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
16.9
345
2189
L04AA01
ATC
[U] ciclosporin
5.4
16.9
33
62
Z51.5
ICD-10 Finland
Palliative care
2.4
16.8
122
536
J01FA06
ATC
roxithromycin; oral
1.6
16.8
587
4276
P01AB01
ATC
metronidazole; oral, rectal
1.6
16.8
598
4379
L26
ICD-10 Finland
Exfoliative dermatitis
35.5
16.7
21
6
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.6
16.6
39
86
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
5.2
16.5
34
67
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.4
16.4
59
178
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
16.3
379
2491
D05BB02
ATC
acitretin; oral
3.9
16.3
47
122
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.0
16.2
72
247
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
16.2
156
772
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
16.2
295
1811
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
16.1
211
1167
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
16.1
105
440
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.7
15.9
37
81
R60.0
ICD-10 Finland
Localized oedema
2.0
15.8
184
976
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
4.1
15.8
44
111
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.2
15.7
61
193
R01AD08
ATC
fluticasone; nasal
1.6
15.6
424
2897
WW200
NOMESCO Finland
Immunization
3.6
15.3
51
146
A03
ICPC
Fever
1.8
15.2
281
1728
N02BE01
ATC
paracetamol; systemic, rectal
1.8
15.1
1328
11905
R06.0
ICD-10 Finland
Dyspnoea
1.6
15.1
398
2695
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
14.9
139
679
J01AA02
ATC
doxycycline; systemic
1.6
14.8
1110
9509
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
14.7
549
4032
J01FA09
ATC
clarithromycin; systemic
1.6
14.7
464
3278
SPAT1263
SPAT
Sampling
1.5
14.6
630
4776
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
14.5
98
417
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.2
14.5
57
182
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.2
14.5
57
182
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
14.5
199
1117
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
14.5
146
735
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
14.5
149
756
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
14.4
620
4694
J05AB01
ATC
aciclovir; systemic
1.7
14.4
338
2218
J02AC01
ATC
fluconazole; systemic
1.5
14.4
584
4366
A04AA02
ATC
granisetron; systemic, transdermal
2.4
14.3
104
458
L51.9
ICD-10 Finland
Erythema multiforme, unspecified
17.7
13.8
21
12
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.8
13.8
68
247
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.7
13.8
76
293
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
20.2
13.8
20
10
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
13.7
445
3157
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
13.6
94
404
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
13.6
104
468
N03AX12
ATC
[U] gabapentin; oral
1.8
13.5
242
1472
L27.9
ICD-10 Finland
Dermatitis due to unspecified substance taken internally
141.2
13.5
14
*
XG410
NOMESCO Finland
Flow-volume spirometry
2.7
13.4
72
274
UJF32
NOMESCO Finland
Coloscopy
1.6
13.3
367
2502
R06AE09
ATC
levocetirizine; oral
1.8
13.3
227
1362
L03AA02
ATC
filgrastim; parenteral
3.0
13.3
57
192
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.1
13.2
124
607
SPAT1254
SPAT
Administration of medicine
1.8
13.2
234
1419
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.7
13.1
72
277
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
13.1
203
1182
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.0
13.1
58
199
N03AX18
ATC
lacosamide; systemic
6.2
12.9
22
36
S97
ICPC
Chronic ulcer skin
2.4
12.9
92
401
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
12.9
735
5857
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
12.9
236
1444
A10AB05
ATC
insulin aspart; parenteral
2.1
12.8
119
580
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
12.8
63
229
A02BC05
ATC
esomeprazole; systemic
1.5
12.7
568
4304
WZC30
NOMESCO Finland
Teaching
1.8
12.7
225
1363
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.3
12.7
32
75
L30.3
ICD-10 Finland
Infective dermatitis
2.9
12.6
60
214
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.8
12.5
37
98
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.0
12.4
56
194
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
12.4
187
1080
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
12.3
371
2575
ZXD05
NOMESCO Finland
Urgent procedure
1.5
12.3
438
3157
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
12.3
147
786
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.3
12.2
46
143
R03AC02
ATC
salbutamol; inhalant
1.5
12.1
812
6654
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
12.0
93
421
TGC00
NOMESCO Finland
Bronchial lavation
3.2
12.0
47
150
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
13.5
11.9
20
15
B01AB05
ATC
enoxaparin; parenteral
1.5
11.9
437
3168
C91.4
ICD-10 Finland
Hairy-cell leukaemia
47.0
11.9
14
*
J01FA10
ATC
azithromycin; systemic
1.5
11.8
858
7120
S76
ICPC
Skin infection other
2.4
11.8
83
360
D02AE01
ATC
carbamide; topical
2.2
11.7
103
491
R03BA02
ATC
budesonide; inhalant
1.6
11.7
272
1773
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
11.6
85
375
R06AX22
ATC
ebastine; oral
1.7
11.6
249
1588
L51.0
ICD-10 Finland
Nonbullous erythema multiforme
19.1
11.6
17
9
AA1AD
NOMESCO Finland
CT of head and brain
1.6
11.5
367
2576
R01AD09
ATC
mometasone; nasal
1.5
11.5
655
5180
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
11.5
614
4796
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
11.4
60
226
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
11.3
169
972
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
11.3
615
4819
L04AB04
ATC
adalimumab; parenteral
3.2
11.3
43
135
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
11.2
273
1798
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.6
11.2
37
106
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
11.1
263
1719
L50.1
ICD-10 Finland
Idiopathic urticaria
5.8
11.0
20
35
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.7
11.0
58
219
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
11.0
161
920
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.9
11.0
24
50
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
10.9
76
329
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
10.8
205
1264
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.3
10.8
27
63
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.6
10.8
62
245
L04AA13
ATC
[U] leflunomide
3.2
10.8
43
139
M54.5
ICD-10 Finland
Low back pain
1.5
10.7
506
3849
M79.6
ICD-10 Finland
Pain in limb
1.4
10.7
591
4632
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
60.4
10.6
12
*
R53
ICD-10 Finland
Malaise and fatigue
1.5
10.5
351
2483
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
4.8
10.5
23
48
M05BA04
ATC
alendronic acid; oral
1.9
10.5
127
682
A02BC03
ATC
lansoprazole; oral
1.5
10.5
399
2903
N05CF01
ATC
zopiclone; oral
1.5
10.5
439
3257
127
Kela drug reimbursment
Transplant complication
3.7
10.4
32
87
Z88.1
ICD-10 Finland
Personal history of allergy to other antibiotic agents
110.8
10.4
11
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
10.4
89
420
M05BX04
ATC
denosumab; parenteral
2.2
10.4
90
427
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
10.3
173
1029
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
10.3
69
293
N05BA04
ATC
oxazepam; oral
1.5
10.2
368
2645
N18.8
ICD-10 Finland
Other chronic renal failure
3.3
10.0
37
114
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
3.9
10.0
29
76
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
9.9
81
376
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.4
9.8
24
55
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
9.8
128
706
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.9
9.7
46
164
TK800
NOMESCO Finland
Hemodialysis
3.4
9.7
35
106
A07AA02
ATC
nystatin; oral
2.1
9.7
88
425
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.2
9.6
81
380
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
9.6
269
1826
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
3.4
9.6
34
102
SPAT1153
SPAT
Removal of sutures
1.5
9.6
427
3197
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.9
9.6
127
703
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
9.6
271
1845
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
9.6
225
1466
318
Kela drug reimbursment
Teriparatide
10.1
9.5
18
18
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.5
9.5
32
93
S18
ICPC
Laceration/cut
1.4
9.4
628
5058
R03DC03
ATC
montelukast; oral
1.6
9.4
242
1611
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.4
559
4413
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
9.4
90
445
J01DA09
ATC
[U] cefadroxil
1.5
9.3
371
2715
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
4.9
9.3
20
41
C07AB07
ATC
bisoprolol; oral
1.4
9.3
625
5037
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
9.3
78
366
N06AX21
ATC
duloxetine; oral
1.7
9.3
170
1037
A07AA09
ATC
vancomycin; oral
4.1
9.3
25
62
R03AC03
ATC
terbutaline; inhalant
1.7
9.2
197
1251
D05AX52
ATC
calcipotriol, combinations; topical
2.2
9.1
72
329
J01CE08
ATC
benzathine benzylpenicillin; parenteral
5.0
9.1
19
38
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.4
9.1
22
50
501
Kela drug reimbursment
Cow's milk and / or soy protein allergy in young children
4.4
9.1
22
50
D07BC01
ATC
betamethasone and antiseptics; topical
1.7
9.1
162
981
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.2
9.1
77
363
L30.0
ICD-10 Finland
Nummular dermatitis
2.5
9.0
56
230
H05AA02
ATC
teriparatide; parenteral
10.1
9.0
17
17
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
36.9
9.0
11
*
L40.1
ICD-10 Finland
Generalized pustular psoriasis
36.9
9.0
11
*
WZA10
NOMESCO Finland
Extensive medical or dental certificate
3.7
9.0
28
77
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.9
9.0
26
68
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
8.9
109
587
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.1
8.9
36
118
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
4.7
8.8
20
43
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.2
8.8
34
108
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
8.8
277
1929
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.3
8.8
64
283
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
9.5
8.8
17
18
B01AB10
ATC
tinzaparin; parenteral
1.8
8.8
141
829
S01GX01
ATC
cromoglicic acid; ophthalmic
1.5
8.7
298
2110
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.0
8.7
91
464
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
8.7
145
860
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.3
8.7
62
272
L04AX04
ATC
lenalidomide; oral
6.6
8.7
21
32
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
8.7
237
1599
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.1
8.6
78
377
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.8
8.6
26
70
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.6
8.6
49
193
SPAT1301
SPAT
No procedures
1.4
8.6
439
3361
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.8
8.6
42
153
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
8.5
125
714
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
3.2
8.5
33
105
X57
ICD-10 Finland
Unspecified privation
2.9
8.5
39
137
M25.5
ICD-10 Finland
Pain in joint
1.4
8.5
441
3384
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
8.5
88
448
153
Kela drug reimbursment
Lenalidomid
6.4
8.5
21
33
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
8.5
60
262
R42
ICD-10 Finland
Dizziness and giddiness
1.5
8.5
303
2166
UJK02
NOMESCO Finland
ERCP
2.8
8.5
40
143
D05AX03
ATC
calcitriol; topical
3.9
8.4
24
62
A02BC01
ATC
omeprazole; systemic
1.5
8.4
368
2737
A10AC01
ATC
insulin (human); parenteral
1.9
8.4
110
607
L88
ICPC
Rheumatoid/seropositive arthritis
2.3
8.4
59
257
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.5
8.4
28
81
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.5
8.4
52
214
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.3
8.4
30
91
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
8.3
61
271
R11
ICD-10 Finland
Nausea and vomiting
1.8
8.3
131
766
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.6
8.3
48
191
SPAT1325
SPAT
Vaccination
1.4
8.3
469
3654
D07CC01
ATC
betamethasone and antibiotics; topical
1.6
8.3
177
1125
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
8.2
96
510
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.5
8.2
52
216
R02
ICPC
Shortness of breath/dyspnoea
1.6
8.2
177
1127
D11AH01
ATC
tacrolimus; topical
4.2
8.2
21
50
N05BA09
ATC
clobazam; oral
6.5
8.2
20
31
SPAT1229
SPAT
Assessment of need for aid
1.9
8.2
103
561
WX002
NOMESCO Finland
Sedation and analgesia
1.5
8.2
262
1829
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.9
8.2
23
59
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.4
8.1
52
217
J47
ICD-10 Finland
Bronchiectasis
3.2
8.1
32
103
L04AB01
ATC
etanercept; parenteral
3.4
8.1
28
83
J46
ICD-10 Finland
Status asthmaticus
2.6
8.1
44
170
L30.8
ICD-10 Finland
Other specified dermatitis
2.6
8.1
44
170
N30.0
ICD-10 Finland
Acute cystitis
1.6
8.1
231
1574
L28
ICPC
Limited function/disability (L)
1.5
8.0
231
1576
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
8.0
204
1355
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
7.9
125
730
C08CA01
ATC
amlodipine; oral
1.4
7.9
473
3711
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
7.9
100
545
B02.9
ICD-10 Finland
Zoster without complication
1.9
7.9
92
488
R06AX13
ATC
loratadine; oral
1.6
7.9
215
1447
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
4.5
7.9
19
43
ZX112
NOMESCO Finland
Subcutaneous
2.8
7.9
39
143
S29
ICPC
Skin symptom/complaint other
1.5
7.9
260
1825
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
7.9
146
893
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.7
7.9
18
39
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
4.7
7.9
18
39
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.8
7.9
37
132
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.5
7.9
49
202
D05AX02
ATC
calcipotriol; topical
2.5
7.9
49
202
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
7.8
127
748
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
7.8
130
771
JN6AD
NOMESCO Finland
CT of torso and neck
3.4
7.8
27
80
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
8.5
7.8
16
19
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.8
7.8
23
61
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
7.8
140
849
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.3
7.8
57
253
L20.0
ICD-10 Finland
Besnier prurigo
1.8
7.8
120
697
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
7.8
136
819
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
7.8
561
4540
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.1
7.8
32
106
EMB30
NOMESCO Finland
Adenotomy
2.4
7.8
52
222
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.6
7.7
42
162
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.5
7.7
26
76
L04AD02
ATC
tacrolimus; systemic
4.0
7.6
21
53
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
18.5
7.6
11
6
J01FA01
ATC
erythromycin; systemic
1.6
7.6
190
1254
M13.9
ICD-10 Finland
Arthritis, unspecified
1.8
7.6
103
575
183
Kela drug reimbursment
Lamotrigin and topiramate
4.1
7.5
20
49
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
7.5
207
1396
J32.4
ICD-10 Finland
Chronic pansinusitis
3.4
7.5
26
77
Z3231
NOMESCO Finland
Registered nurse
1.4
7.5
373
2831
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.6
7.5
43
171
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.9
7.5
33
114
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
7.4
98
542
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
7.4
166
1066
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.5
7.4
18
28
S70
ICPC
Herpes zoster
2.6
7.4
42
166
C90.0
ICD-10 Finland
Multiple myeloma
3.8
7.4
22
59
N03AB02
ATC
phenytoin; systemic
3.8
7.4
22
59
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.7
7.3
39
149
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
7.3
398
3068
R51.80
ICD-10 Finland
Headache
1.5
7.3
227
1573
J20
ICD-10 Finland
Acute bronchitis
1.7
7.3
139
857
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
7.3
114
665
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.5
7.3
24
69
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.9
7.3
92
503
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
15.8
7.2
11
7
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
7.2
732
6220
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
4.5
7.2
17
38
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.5
7.1
24
70
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
7.1
445
3508
L04AC05
ATC
ustekinumab; parenteral
8.0
7.1
15
19
ZY010
NOMESCO Finland
Hospital outpatient
1.9
7.1
81
428
Z71.8
ICD-10 Finland
Other specified counselling
1.4
7.1
428
3357
M79.1
ICD-10 Finland
Myalgia
1.5
7.1
199
1350
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
7.0
64
311
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
7.0
158
1017
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
7.0
208
1427
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
7.0
363
2773
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
7.0
180
1196
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
7.0
84
452
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.5
7.0
41
165
N05BB01
ATC
hydroxyzine; systemic
1.9
7.0
92
510
S06
ICPC
Rash localized
2.0
6.9
78
410
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.9
6.9
31
108
C08CA13
ATC
lercanidipine; oral
1.6
6.9
175
1159
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.6
6.9
22
62
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.5
6.9
23
67
L40.9
ICD-10 Finland
Psoriasis, unspecified
3.4
6.8
24
72
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.8
424
3335
WX892
NOMESCO Finland
Monitored bed care
1.8
6.8
102
587
N05BA01
ATC
diazepam; systemic, rectal
1.6
6.8
176
1170
M05BA07
ATC
risedronic acid; oral
2.3
6.8
47
204
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
6.8
70
357
B35.3
ICD-10 Finland
Tinea pedis
2.2
6.8
57
269
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.3
6.8
17
40
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
6.7
1014
9081
J01FA15
ATC
telithromycin; oral
1.7
6.7
127
781
J01CA04
ATC
amoxicillin; systemic
1.4
6.7
1200
11034
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
6.7
164
1076
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.5
6.7
22
63
ZXE00
NOMESCO Finland
One hour or less
1.3
6.7
530
4325
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.5
6.7
42
174
M01CB01
ATC
sodium aurothiomalate; parenteral
3.4
6.7
23
68
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.9
6.7
31
110
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.6
6.6
36
139
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.9
6.6
30
105
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.2
6.6
53
245
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.4
6.6
45
194
J01DC02
ATC
cefuroxime; systemic
1.9
6.6
77
410
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
12.3
6.6
11
9
J04AB02
ATC
rifampicin; systemic
3.5
6.6
22
64
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.4
6.6
23
69
N06AX16
ATC
venlafaxine; oral
1.5
6.6
193
1321
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.6
6.6
36
140
L50
ICD-10 Finland
Urticaria
2.8
6.6
32
117
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.5
215
1506
UKC02
NOMESCO Finland
Cystoscopy
1.5
6.5
189
1289
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.7
6.5
33
123
B03XA02
ATC
darbepoetin alfa; parenteral
2.7
6.5
33
123
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
6.5
33
123
M03BX02
ATC
tizanidine; oral
1.3
6.5
823
7172
J01EA01
ATC
trimethoprim; systemic
1.4
6.5
361
2785
N02BF02
ATC
pregabalin; oral
1.9
6.5
78
419
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
6.5
292
2172
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.9
6.5
29
101
B34.9
ICD-10 Finland
Viral infection, unspecified
2.3
6.5
46
202
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.5
6.5
40
165
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
6.5
132
829
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.1
6.5
61
301
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
6.5
86
478
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.2
6.5
25
80
A01AB09
ATC
miconazole; local oral
1.7
6.4
119
728
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
3.9
6.4
18
46
XCK00
NOMESCO Finland
Perimetry
1.9
6.4
80
435
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
6.4
30
107
B01AC04
ATC
clopidogrel; oral
1.5
6.4
192
1318
K07
ICPC
Swollen ankles/oedema
2.0
6.4
65
329
134
Kela drug reimbursment
General erythroderma
7.4
6.4
14
19
H25.8
ICD-10 Finland
Other senile cataract
1.6
6.4
131
823
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
6.4
48
216
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.3
6.4
45
197
L30
ICD-10 Finland
Other dermatitis
2.5
6.4
37
148
128
Kela drug reimbursment
Cancers of female genital organs
2.7
6.4
32
119
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
4.1
6.4
17
42
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.8
6.3
97
563
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.8
6.3
31
114
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.5
6.3
21
61
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
3.9
6.3
18
47
A07EA06
ATC
budesonide; oral, local oral
2.2
6.3
53
251
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
6.2
185
1268
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.4
6.2
40
168
SPAT1260
SPAT
Consultation of another employee
1.5
6.2
230
1650
XG466
NOMESCO Finland
Sleep oxymetry
2.4
6.2
42
181
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.0
6.2
18
36
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.2
374
2924
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.4
6.2
41
175
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
6.3
6.2
15
24
H66.9
ICD-10 Finland
Otitis media, unspecified
1.7
6.2
99
583
UDM02
NOMESCO Finland
Sinoscopy
2.6
6.1
35
139
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
6.1
178
1215
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.2
6.1
51
240
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
6.1
90
517
S01
ICPC
Pain/tenderness of skin
2.0
6.1
63
322
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
6.1
742
6414
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.6
6.1
33
128
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.9
6.1
27
94
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
6.1
237
1718
K83.0
ICD-10 Finland
Cholangitis
3.1
6.1
24
78
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
6.0
268
1988
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
6.0
160
1071
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.5
6.0
20
58
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.8
6.0
28
100
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1008
6516
2.58
67.09
11.9
6.2
0.21
0.19
e9/l
1.99
934
5715
115
207
5.92
61.74
2.1
1.7
—
—
—
0
0
1071
7307
2.53
60.51
16.9
8.9
4.23
4.05
e9/l
1.65
990
6388
134
291
4.95
58.38
2.1
1.6
—
—
—
0
0
270
965
3.18
58.04
4.1
2.9
10.20
10.46
g/l
0.36
258
881
131
287
4.90
56.45
2.2
1.6
—
—
—
0
0
419
1936
2.60
55.44
2.5
1.8
—
—
—
0
0
120
249
5.14
55.08
7.5
6.0
322.88
308.56
iu/ml
0.03
24
34
911
5938
2.31
54.66
12.2
6.0
3.08
2.83
%
1.54
867
5545
944
6301
2.29
52.71
10.0
6.0
10.49
11.22
umol/l
0.94
909
5971
927
6154
2.27
52.27
12.3
6.1
26.46
28.32
%
5.12
882
5778
916
6072
2.26
51.54
11.7
5.9
58.41
56.94
%
2.88
871
5697
220
758
3.22
49.90
2.4
1.8
1.16
1.51
g/l
1.13
204
700
244
935
2.91
45.77
6.2
4.0
0.61
0.67
%
0.21
145
303
303
1306
2.64
45.29
6.5
4.2
246.78
249.52
u/l
0.11
283
1233
833
5494
2.12
45.14
9.8
6.0
1.21
1.21
mmol/l
2.27
764
5018
890
6027
2.13
44.88
11.5
6.7
1.21
1.21
mmol/l
0.74
754
5151
222
834
2.94
43.04
1.6
1.2
395.12
210.36
u/ml
1.20
209
765
151
456
3.56
42.03
2.6
1.9
1.24
1.94
ug/l
0.45
137
402
243
973
2.78
41.77
3.9
2.8
70.15
69.54
e9/l
0.09
192
740
805
5365
2.05
40.98
13.6
14.3
1.21
1.23
inr
0.30
247
1575
133
375
3.79
40.96
2.8
1.6
0.23
0.24
g/l
0.50
123
357
60
84
7.39
40.87
2.5
2.8
—
—
—
0
0
135
388
3.72
40.42
2.8
1.6
1.12
1.20
g/l
1.61
128
366
223
882
2.79
39.11
2.0
1.6
—
—
—
0
0
93
208
4.69
38.93
2.0
1.6
—
—
—
0
0
93
208
4.69
38.93
2.0
1.6
—
—
—
0
0
1203
9405
2.28
38.80
14.6
7.3
81.09
78.20
u/l
1.06
1161
8850
87
185
4.92
38.68
3.0
3.3
2.07
1.28
%
0.77
78
165
81
166
5.09
37.58
2.2
1.7
—
—
—
0
0
291
1343
2.44
37.07
2.1
1.7
—
—
—
0
0
291
1351
2.42
36.55
2.2
1.8
—
—
—
0
0
68
123
5.74
36.18
2.1
1.7
—
—
—
0
0
70
132
5.51
35.62
2.1
1.8
—
—
—
0
0
283
1326
2.39
34.68
3.5
2.9
1.83
1.77
%
0.38
254
1179
87
203
4.48
34.53
3.8
3.6
849.00
1830.63
u/ml
—
6
16
124
374
3.52
34.46
3.1
2.9
—
—
—
0
0
763
5207
1.92
34.02
8.2
4.8
34.49
35.74
g/l
6.86
708
4856
70
140
5.19
33.38
2.1
1.6
—
—
—
0
0
362
1909
2.17
33.30
6.2
3.6
0.80
0.82
mmol/l
2.26
348
1793
233
1032
2.48
32.17
11.4
7.6
9.64
9.36
mmol/l
0.25
220
984
56
94
6.14
32.15
1.6
1.7
—
—
—
0
0
356
1902
2.13
31.47
3.0
2.4
11.87
13.19
umol/l
3.23
334
1770
254
1189
2.36
30.95
3.1
2.1
330.34
376.49
nmol/l
3.03
238
1097
86
218
4.12
30.63
1.9
1.5
—
—
—
0
0
71
157
4.69
30.10
1.8
1.5
—
—
—
0
0
583
3755
1.89
29.98
3.6
2.5
54.14
80.50
u/l
0.66
548
3477
331
1750
2.14
29.91
3.0
2.4
2.28
2.34
g/l
1.13
304
1623
313
1624
2.16
29.66
3.1
2.4
21.72
22.80
%
0.64
270
1388
306
1582
2.17
29.22
9.3
5.7
1.08
1.06
mmol/l
0.84
286
1457
1072
8404
1.91
28.92
6.1
4.4
38.25
2612.02
e6/l
—
8
115
658
4448
1.84
28.68
4.5
3.5
49.09
43.79
ng/l
0.16
480
2955
942
7119
1.83
28.23
7.1
4.8
6.68
6.62
mmol/l
0.31
904
6613
70
163
4.45
27.84
1.9
1.5
—
—
—
0
0
1139
9190
1.92
27.08
7.5
4.1
15.37
11.86
mm/h
9.63
1070
8491
547
3548
1.84
26.82
2.8
2.2
154.66
237.09
u/l
1.81
518
3340
117
397
3.11
26.80
1.9
1.6
217.78
150.00
titre
—
9
14
104
329
3.32
26.75
1.4
1.3
—
—
—
0
0
56
112
5.15
26.70
3.3
2.9
58.79
54.93
%
0.57
47
98
115
388
3.12
26.60
3.7
1.9
—
—
—
0
0
35
43
8.31
26.56
2.1
2.8
799.00
55857.88
u/ml
—
5
8
437
2648
1.91
26.49
2.0
1.5
2.26
2.29
g/l
0.14
313
1592
53
105
5.19
25.54
1.9
1.5
—
—
—
0
0
53
105
5.19
25.54
1.9
1.5
—
—
—
0
0
53
105
5.19
25.54
1.9
1.5
—
—
—
0
0
72
186
4.01
24.99
1.8
1.5
—
—
—
0
0
509
3290
1.82
24.85
3.6
3.1
1592.87
1227.57
ng/l
0.86
435
2786
203
946
2.32
24.70
4.9
2.9
65.42
66.71
g/l
1.42
185
860
498
3211
1.81
24.43
2.8
2.2
3.13
2.93
mg/l
1.14
425
2727
179
799
2.40
24.00
6.6
4.3
5.10
5.15
kpa
0.36
170
767
173
763
2.43
23.81
6.5
4.3
1.71
1.76
mmol/l
0.06
131
567
472
3030
1.80
23.29
4.0
2.7
2743.07
5969.17
umol/l
1.25
423
2654
47
91
5.30
23.24
3.1
2.8
612.46
605.05
e6/l
0.02
41
79
61
147
4.28
23.23
1.9
1.6
—
—
—
0
0
61
147
4.28
23.23
1.9
1.6
—
—
—
0
0
46
88
5.36
23.05
3.2
2.9
0.23
0.20
e9/l
0.31
41
78
124
473
2.76
22.97
1.4
1.2
0.26
1.02
u/ml
0.72
13
33
109
392
2.92
22.52
1.7
1.5
3.42
0.20
iu/ml
0.57
18
71
227
1149
2.14
22.47
3.3
2.3
0.21
0.21
g/l
0.65
205
1070
129
510
2.67
22.28
2.1
1.9
1.63
1.49
g/l
0.75
116
446
27
31
8.85
21.57
2.0
2.1
—
—
—
0
0
82
256
3.33
21.54
4.2
3.8
59.89
57.27
%
0.77
82
256
44
88
5.12
20.99
2.2
1.7
—
—
—
0
0
88
292
3.14
20.92
1.5
1.3
—
—
—
0
0
87
291
3.11
20.40
1.5
1.5
—
—
—
0
0
814
6227
1.65
20.28
5.2
3.6
0.00
0.00
estimate
0.75
184
1267
431
2796
1.75
19.99
2.0
1.8
1.20
1.16
mg/l
0.15
351
2119
152
688
2.34
19.65
1.8
1.6
—
—
—
0
0
77
245
3.26
19.62
3.9
3.6
4.51
4.16
e9/l
0.52
77
245
502
3418
1.70
19.44
4.3
3.1
0.46
0.45
e6/l
0.03
417
2595
407
2621
1.75
19.26
3.7
2.5
5.50
6.68
e6/l
1.11
381
2360
809
6230
1.63
19.22
6.7
4.9
0.00
0.00
estimate
0.50
184
1199
117
474
2.59
19.22
2.5
1.8
—
—
—
0
0
80
265
3.13
19.08
1.8
1.4
—
13.91
—
0
5
814
6294
1.62
18.89
5.3
3.6
0.00
0.01
estimate
0.80
177
1163
75
242
3.21
18.68
1.8
1.5
117.84
110.66
u/ml
0.35
19
42
699
5227
1.62
18.46
2.8
2.3
74.88
76.73
nmol/l
1.00
641
4701
81
277
3.03
18.30
1.6
1.3
358.52
240.59
u/ml
1.68
52
157
107
426
2.62
18.20
2.1
1.7
—
—
—
0
0
34
62
5.59
17.94
2.1
1.5
—
—
—
0
0
34
62
5.59
17.94
2.1
1.5
—
—
—
0
0
756
5793
1.60
17.82
3.8
2.8
165.52
111.60
ug/l
1.59
699
5363
305
1846
1.81
17.66
2.5
2.2
29.62
29.66
s
0.03
292
1788
122
525
2.44
17.63
7.8
4.7
24.77
24.80
mmol/l
0.04
114
501
27
40
6.85
17.44
1.4
1.4
—
—
—
0
0
30
50
6.10
17.34
2.2
1.6
—
—
—
0
0
30
50
6.10
17.34
2.2
1.6
—
—
—
0
0
445
3009
1.67
17.31
3.3
2.2
—
—
—
0
0
30
51
5.98
17.01
2.2
1.6
—
—
—
0
0
96
377
2.65
16.78
2.7
3.3
3.83
3.56
g/l
0.83
90
358
1388
12559
2.07
16.28
29.2
13.4
21.57
22.91
mg/l
1.05
1246
9872
521
3715
1.61
16.19
4.5
3.2
29.86
77.92
e6/l
1.74
436
2859
50
139
3.68
15.70
1.7
1.6
60.64
56.43
%
0.30
36
93
88
345
2.64
15.44
2.3
2.2
13.72
11.56
mg/l
0.75
80
312
97
402
2.51
15.20
2.1
2.2
188.55
444.68
ug/l
1.20
87
380
87
343
2.63
15.10
5.7
4.1
8.18
1.76
ratio
—
9
29
88
351
2.60
14.92
5.7
4.1
52.79
68.14
mg/l
0.33
68
288
88
351
2.60
14.92
5.7
4.1
48.04
64.28
mg/l
0.27
68
289
336
2185
1.69
14.85
1.9
1.7
1231.30
1183.77
nmol/l
0.39
256
1631
474
3360
1.59
14.84
6.0
3.9
0.00
0.01
estimate
1.28
170
1163
147
737
2.10
14.72
1.6
1.5
—
—
—
0
0
70
254
2.84
14.26
1.6
1.2
3.57
5.93
u/ml
—
7
20
116
536
2.26
14.25
2.3
2.0
37.37
39.07
u/l
0.38
102
476
752
5947
1.52
14.17
3.5
2.6
—
—
—
0
0
72
267
2.78
14.08
1.5
1.3
—
—
—
0
0
85
347
2.53
13.76
1.6
1.2
16.90
38.17
u/ml
0.54
11
17
265
1648
1.73
13.70
3.1
2.4
138.60
113.98
ug/g
0.57
206
1291
80
318
2.60
13.67
1.5
1.2
18.47
2.56
u/ml
0.57
16
35
81
325
2.58
13.59
1.5
1.2
30.97
8.44
u/ml
0.92
22
52
32
71
4.58
13.56
2.9
2.7
34.53
43.54
%
1.42
19
40
46
134
3.51
13.51
1.3
1.2
—
—
—
0
0
221
1317
1.79
13.21
8.5
7.7
1.25
1.06
mmol/l
0.31
170
1039
64
231
2.85
13.18
2.3
1.5
—
—
—
0
0
221
1318
1.79
13.18
8.6
7.7
5.02
5.08
kpa
0.41
207
1260
221
1318
1.79
13.18
8.6
7.7
12.39
12.28
kpa
0.10
206
1260
33
77
4.36
13.15
2.3
1.5
—
—
—
0
0
31
69
4.56
13.09
1.1
1.0
—
—
—
0
0
201
1173
1.82
12.87
8.9
8.2
95.44
95.61
%
0.14
188
1133
139
719
2.03
12.78
7.9
7.4
24.72
24.45
mmol/l
0.39
131
686
29
63
4.67
12.61
2.5
1.6
—
—
—
0
0
321
2150
1.62
12.41
1.3
1.3
31.12
29.42
iu/ml
0.09
101
691
310
2060
1.63
12.37
1.3
1.3
11.25
10.54
u/ml
0.06
110
794
619
4796
1.49
12.33
5.7
3.8
—
—
—
0
0
535
4026
1.50
12.29
5.6
3.2
33.52
30.87
u/l
0.64
507
3833
193
1130
1.81
12.20
6.5
4.4
1.89
1.85
mmol/l
0.06
166
924
553
4205
1.49
12.01
4.8
3.4
2.34
2.36
mmol/l
2.59
485
3708
28
62
4.58
11.91
1.6
1.2
—
—
—
0
0
28
63
4.51
11.69
2.5
1.6
—
—
—
0
0
28
63
4.51
11.69
1.6
1.2
—
—
—
0
0
20
16
12.65
11.63
1.2
3.4
—
—
—
0
0
205
1242
1.75
11.52
4.7
3.2
—
—
—
0
0
73
303
2.48
11.44
1.6
1.4
—
—
—
0
0
424
3079
1.52
11.38
6.4
4.0
91.17
90.78
%
0.12
411
2993
77
331
2.40
11.19
2.2
1.6
—
—
—
0
0
419
3051
1.51
11.05
1.3
1.3
1.12
1.70
u/ml
0.68
104
788
182
1083
1.77
10.86
9.7
8.4
117.15
120.74
g/l
1.58
177
1055
367
2617
1.53
10.62
1.6
1.6
—
—
—
0
0
1373
12700
1.75
10.50
29.0
15.4
139.33
139.60
mmol/l
3.82
1347
12348
219
1397
1.66
10.13
5.0
3.0
7.01
7.79
umol/l
0.23
190
1196
1373
12729
1.73
10.03
29.3
15.5
3.96
3.96
mmol/l
0.21
1348
12354
162
955
1.78
9.97
3.6
2.7
64.67
66.60
ml/min/173m2
0.24
76
383
20
39
5.18
9.85
3.7
2.2
—
—
—
0
0
354
2542
1.51
9.82
1.7
1.7
123051283.10
30307756.33
pmol/l
0.86
295
2115
23
51
4.56
9.79
1.7
1.2
—
—
—
0
0
23
51
4.56
9.79
1.7
1.2
—
—
—
0
0
44
153
2.93
9.75
1.6
1.3
—
—
—
0
0
379
2764
1.49
9.75
5.2
4.0
1.02
1.02
kg/l
0.24
45
391
321
2261
1.53
9.75
4.7
3.7
136.41
382.76
ng/l
2.80
235
1692
58
234
2.54
9.68
1.9
1.4
—
—
—
0
0
35
107
3.32
9.61
1.4
1.4
—
—
—
0
0
617
4945
1.41
9.55
2.2
1.9
97.83
95.36
pmol/l
0.63
379
2550
44
155
2.89
9.53
1.6
1.3
—
—
—
0
0
44
155
2.89
9.53
1.6
1.3
—
—
—
0
0
64
273
2.40
9.50
2.0
1.7
28694.79
12659.27
e6/l
0.77
48
200
391
2885
1.48
9.45
1.7
1.5
19.25
20.72
nmol/l
1.07
342
2451
136
775
1.83
9.36
1.3
1.3
50.51
46.94
au/ml
—
8
50
28
75
3.78
9.35
1.8
1.4
39.40
19.82
u/ml
—
5
11
21
29
7.33
9.22
1.2
1.3
—
—
—
0
0
57
234
2.49
9.19
3.3
2.5
15.78
16.26
%
0.34
33
121
32
96
3.38
9.06
1.7
1.4
34.65
34.98
%
0.02
25
62
47
179
2.68
8.83
1.1
1.2
—
—
—
0
0
42
152
2.81
8.69
1.6
1.3
—
—
—
0
0
42
152
2.81
8.69
1.6
1.3
—
—
—
0
0
40
141
2.89
8.68
3.2
2.2
33.53
32.35
pg
1.19
40
141
144
856
1.75
8.61
2.5
2.4
30.89
26.89
au/ml
0.16
15
70
42
153
2.79
8.59
1.6
1.3
—
—
—
0
0
23
57
4.08
8.53
1.3
1.2
—
—
—
0
0
31
95
3.31
8.50
1.4
1.1
59.00
81.00
u/ml
—
6
9
87
446
2.01
8.24
4.2
2.6
3.40
3.65
g/l
1.17
81
406
87
447
2.00
8.19
4.2
2.6
7.31
7.39
g/l
0.22
81
406
87
447
2.00
8.19
4.2
2.6
—
—
—
0
0
1106
9917
1.41
8.17
4.8
4.1
14.87
14.71
pmol/l
1.27
1001
9044
940
8206
1.37
8.16
5.0
3.0
55.84
44.10
u/l
2.99
885
7682
290
2075
1.49
8.04
3.3
2.7
1.10
1.09
e6/l
0.01
185
1165
156
977
1.66
7.71
6.9
3.4
1.22
1.23
mmol/l
0.60
140
840
45
180
2.55
7.70
1.1
1.3
—
—
—
0
0
32
107
3.03
7.64
4.2
2.3
—
—
—
0
0
31
102
3.08
7.61
2.2
1.1
—
—
—
0
0
22
58
3.83
7.53
2.3
4.1
—
—
—
0
0
154
973
1.65
7.36
5.5
3.9
111.94
83.76
ng/l
2.03
132
861
38
144
2.68
7.25
1.2
1.1
—
—
—
0
0
428
3346
1.39
7.23
3.7
3.3
791.88
312.95
mg/l
0.80
263
2143
23
65
3.58
7.15
1.3
1.3
—
63.33
—
0
9
32
113
2.87
6.97
1.2
1.2
74.69
54.39
u/l
0.60
32
106
70
356
2.01
6.82
6.1
6.0
1.45
1.49
mg/l
0.16
64
330
82
441
1.91
6.81
1.6
1.8
—
—
—
0
0
79
423
1.91
6.65
3.6
2.7
2.96
3.01
g/l
0.14
73
382
104
608
1.76
6.62
11.8
11.0
—
—
—
0
0
466
3740
1.35
6.57
3.6
3.2
7.00
7.53
mmol/l
1.87
384
3180
74
390
1.94
6.53
3.4
2.8
1.44
1.38
g/l
0.03
64
345
69
356
1.98
6.48
1.3
1.5
257.37
291.96
ug/g
0.67
36
205
1250
11609
1.41
6.31
22.5
12.3
81.99
83.02
ml/min/173m2
0.77
1085
9464
25
82
3.08
6.20
1.4
1.3
—
—
—
0
0
149
975
1.58
6.18
2.4
2.5
6.12
6.98
ug/l
0.29
124
851
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
69
363
1.94
6.14
3.9
3.4
0.31
0.37
u/ml
0.78
45
200
11
11
10.06
6.03
2.3
4.6
—
—
—
0
0
28
100
2.83
6.01
1.1
1.0
—
—
—
0
0
76
418
1.86
5.93
4.4
2.7
9.56
10.45
g/l
0.67
70
376
143
937
1.58
5.90
4.0
3.0
165.11
215.22
ng/l
0.84
129
854
65
341
1.95
5.85
1.2
1.1
—
—
—
0
0
437
3525
1.33
5.84
4.4
3.8
9.86
8.76
mg/mmol
0.21
267
2223
31
119
2.64
5.82
1.5
1.3
—
—
—
0
0
17
45
3.81
5.82
6.7
4.6
—
—
—
0
0
41
181
2.30
5.75
4.6
5.2
383.09
372.26
umol/l
0.17
33
159
261
1950
1.41
5.63
3.6
2.9
4.02
2.84
e6/l
0.76
153
1046
65
347
1.91
5.57
3.3
2.7
0.00
0.03
g/l
0.86
60
320
41
184
2.26
5.54
1.1
1.1
—
—
—
0
0
70
385
1.86
5.48
1.6
1.5
12.72
9.91
u/l
0.83
60
307
72
400
1.84
5.46
1.3
1.3
—
—
—
0
0
948
8530
1.29
5.42
3.7
3.2
—
—
—
0
0
115
731
1.62
5.40
11.2
9.0
1.42
1.36
%
0.26
110
725
22
73
3.04
5.38
1.4
1.5
—
—
—
0
0
22
73
3.04
5.38
1.4
1.5
—
—
—
0
0
17
48
3.57
5.33
1.5
1.3
4.00
5.55
%
—
5
11
1391
13261
1.51
5.32
19.7
10.0
27.09
25.37
u/l
2.37
1362
12797
1247
11665
1.36
5.30
5.8
4.8
1.96
2.14
mu/l
0.45
1147
10734
70
391
1.83
5.23
1.2
1.1
—
—
—
0
0
80
469
1.74
5.10
6.8
6.2
1.51
1.58
%
0.40
74
441
41
191
2.18
5.09
1.3
1.1
—
—
—
0
0
113
727
1.60
5.06
11.3
9.1
0.74
0.68
%
1.01
108
722
28
110
2.57
5.06
1.5
1.4
142186.72
101402.93
e6/l
0.11
18
72
1190
11085
1.32
4.97
6.5
5.4
39.90
39.44
mmol/mol
0.83
1093
10289
199
1449
1.43
4.95
4.6
4.3
32.18
32.44
%
0.12
147
986
69
393
1.79
4.86
1.2
1.1
—
—
—
0
0
51
264
1.96
4.82
1.7
1.2
50.77
34.91
u/ml
—
7
20
11
17
6.51
4.77
2.8
1.8
—
—
—
0
0
50
259
1.96
4.72
2.5
2.3
122.80
129.76
g/l
1.07
41
194
197
1444
1.42
4.72
11.5
7.0
—
—
—
0
0
62
348
1.81
4.60
1.3
1.3
—
—
—
0
0
50
262
1.94
4.58
8.0
8.7
105.40
105.18
mmol/l
0.13
45
239
23
87
2.67
4.50
1.4
1.3
—
—
—
0
0
27
111
2.46
4.48
1.7
1.2
0.47
0.79
u/ml
0.27
21
59
16
49
3.29
4.47
5.1
2.0
15.62
179.20
ug/l
0.51
16
44
25
101
2.50
4.31
1.2
1.5
—
—
—
0
0
287
2270
1.32
4.26
4.4
2.9
2.45
2.45
mmol/l
0.13
258
1999
15
46
3.28
4.19
1.4
1.7
—
1224630.00
—
0
5
14
41
3.44
4.19
1.2
1.2
—
—
—
0
0
10
17
5.91
4.13
2.5
1.4
—
—
—
0
0
158
1142
1.43
4.10
3.0
2.4
35.77
39.50
u/l
0.21
135
963
161
1170
1.42
4.06
4.7
4.1
16.76
21.75
ug/l
0.21
129
943
108
729
1.52
3.97
2.1
2.1
12.09
12.31
nmol/l
0.08
96
646
18
64
2.83
3.96
1.6
1.4
—
—
—
0
0
14
43
3.28
3.91
1.2
1.2
—
—
—
0
0
23
94
2.47
3.89
1.4
1.3
—
—
—
0
0
23
95
2.44
3.81
1.4
1.3
—
—
—
0
0
116
806
1.47
3.72
2.9
3.3
4.43
4.53
pmol/l
0.37
102
709
14
39
3.61
3.70
1.2
1.2
—
—
—
0
0
15
50
3.02
3.69
1.1
1.1
205.70
178.07
iu/ml
0.20
15
50
190
1445
1.36
3.66
2.0
1.7
1.45
1.44
%
0.04
170
1273
22
91
2.44
3.64
1.1
1.2
—
—
—
0
0
60
362
1.68
3.54
3.6
2.6
37.36
37.75
g/l
0.21
54
321
9
17
5.32
3.51
1.3
1.4
—
—
—
0
0
8
13
6.18
3.50
1.3
1.2
—
—
—
0
0
12
32
3.77
3.39
1.7
1.4
24.14
26.90
%
—
7
21
45
256
1.78
3.28
1.4
1.3
—
—
—
0
0
45
256
1.78
3.28
1.4
1.3
—
—
—
0
0
13
43
3.04
3.25
1.1
1.1
—
—
—
0
0
13
39
3.35
3.22
1.2
1.2
—
—
—
0
0
8
15
5.35
3.19
1.1
1.3
—
—
—
0
0
11
29
3.81
3.18
1.0
1.0
—
—
—
0
0
9
20
4.52
3.11
1.3
1.3
—
—
—
0
0
15
56
2.70
3.06
2.7
2.6
—
—
—
0
0
6
8
7.52
3.05
2.2
1.1
—
—
—
0
0
6
8
7.52
3.05
1.8
4.9
—
—
—
0
0
16
62
2.60
3.05
1.1
1.1
38.06
14.19
u/l
1.20
16
54
21
93
2.28
3.04
3.3
2.4
648.73
604.49
ml
0.16
15
61
72
474
1.54
3.03
1.5
1.3
236.10
246.82
miu/ml
0.08
29
236
13
45
2.90
3.03
3.1
4.0
—
30.81
—
0
8
5
5
10.03
2.98
9.8
12.2
—
—
—
0
0
17
69
2.48
2.96
1.8
1.4
15.12
27.79
umol/l
1.45
17
62
1162
11011
1.23
2.95
29.8
16.1
15.19
14.73
%
1.94
1152
10813
24
114
2.12
2.95
8.7
3.6
—
—
—
0
0
40
228
1.77
2.93
1.8
1.9
4.29
4.83
mmol/24h
0.54
33
203
8
17
4.72
2.92
1.0
1.3
—
—
—
0
0
8
17
4.72
2.92
1.3
1.1
—
—
—
0
0
8
17
4.72
2.92
1.3
1.1
—
—
—
0
0
10
27
3.72
2.88
1.2
1.3
—
—
—
0
0
1441
14033
1.42
2.88
39.2
19.9
39.27
40.26
%
2.06
1361
13160
16
64
2.52
2.87
1.1
1.1
126.63
72.04
u/l
1.44
16
57
1441
14039
1.41
2.81
39.4
19.8
254.79
253.80
e9/l
0.21
1420
13670
27
137
1.99
2.81
2.5
2.2
15.33
25.36
mg/l
—
6
34
17
72
2.38
2.73
1.2
1.2
—
—
—
0
0
10
29
3.46
2.69
1.2
1.1
78.90
95.10
%
—
10
29
1441
14050
1.40
2.68
39.3
19.8
4.36
4.48
e12/l
13.68
1420
13645
1441
14050
1.40
2.68
39.3
19.8
7.06
6.72
e9/l
2.71
1418
13637
9
24
3.77
2.67
1.1
1.2
—
—
—
0
0
1208
11532
1.22
2.64
4.2
3.8
1.33
1.26
mmol/l
2.30
1098
10581
1441
14055
1.39
2.63
39.5
19.9
130.84
134.43
g/l
16.57
1428
13851
47
290
1.64
2.62
1.6
1.6
34.87
14.58
e6/l
0.43
38
228
47
290
1.64
2.62
1.7
1.7
95.70
1371.45
e6/l
0.76
40
236
12
41
2.94
2.62
1.3
1.3
—
—
—
0
0
12
41
2.94
2.62
1.3
1.1
—
—
—
0
0
56
361
1.57
2.62
1.1
1.1
3.20
6.39
u/ml
—
6
48
6
11
5.47
2.54
1.3
1.3
—
—
—
0
0
10
31
3.24
2.52
1.1
1.3
—
—
—
0
0
85
604
1.43
2.51
2.8
2.2
1999.25
5392.25
u/l
1.34
33
257
13
51
2.56
2.44
1.5
1.3
169.69
159.84
mmol/24h
0.17
13
51
49
312
1.59
2.43
1.2
1.2
—
—
—
0
0
19
90
2.12
2.39
1.0
1.1
11.12
8.73
iu/ml
—
8
26
5
8
6.27
2.37
3.0
2.1
3.00
5.10
mg/l
—
5
8
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
78
2.19
2.31
1.2
1.2
—
—
—
0
0
6
13
4.63
2.27
1.0
1.4
—
—
—
0
0
1234
11865
1.20
2.19
5.2
4.3
5.96
5.86
mmol/l
1.25
1120
10806
22
115
1.93
2.16
2.4
2.3
—
—
—
0
0
6
14
4.30
2.15
1.5
1.1
9.87
29.03
u/l
—
6
9
7
19
3.70
2.15
1.4
1.1
—
—
—
0
0
33
198
1.68
2.09
1.2
1.1
14.00
88.26
iu/ml
—
9
50
19
96
1.99
2.05
1.1
1.2
—
—
—
0
0
41
262
1.58
2.05
1.1
1.1
6.06
7.13
u/ml
0.13
25
151
9
32
2.82
2.00
1.0
1.2
—
—
—
0
0
14
64
2.20
1.94
3.4
2.7
41264.29
39164.14
ug/l
0.31
14
64
5
11
4.56
1.94
1.6
1.1
—
—
—
0
0
8
27
2.97
1.93
1.1
1.1
—
—
—
0
0
20
106
1.90
1.91
1.9
1.3
24541.71
106954.96
e6/l
0.70
14
56
1247
12047
1.18
1.87
4.7
4.2
4.57
4.66
mmol/l
2.56
1148
11186
98
755
1.32
1.83
1.3
1.4
—
—
—
0
0
42
278
1.53
1.83
3.5
2.4
88.70
110.01
ug/min
0.19
26
173
13
60
2.18
1.78
1.5
1.1
1579.38
1527.45
miu/ml
0.04
13
60
11
47
2.35
1.78
1.4
1.3
—
—
—
0
0
19
102
1.87
1.76
1.2
1.1
—
—
—
0
0
19
102
1.87
1.76
1.2
1.1
—
—
—
0
0
1265
12253
1.18
1.75
5.1
4.6
2.69
2.75
mmol/l
1.37
1159
11307
31
194
1.61
1.72
1.1
1.1
5.13
4.62
u/ml
0.11
18
90
7
24
2.93
1.72
4.9
5.7
—
—
—
0
0
19
103
1.86
1.72
1.2
1.2
—
—
—
0
0
23
134
1.73
1.66
2.2
2.2
—
—
—
0
0
6
19
3.17
1.66
1.2
1.1
—
—
—
0
0
5
14
3.58
1.61
8.6
5.9
—
—
—
0
0
28
175
1.61
1.58
1.0
1.1
5.79
5.91
u/ml
0.01
14
65
7
26
2.70
1.58
1.6
1.3
—
—
—
0
0
1234
11962
1.16
1.54
4.6
4.2
1.43
1.48
mmol/l
4.49
1129
11042
18
100
1.81
1.53
1.0
1.1
—
—
—
0
0
5
15
3.34
1.52
2.8
2.5
—
—
—
0
0
23
138
1.68
1.52
1.7
1.3
32.73
32.38
g/l
0.04
23
123
17
93
1.84
1.51
2.2
1.4
0.64
1.22
promille
1.15
11
76
18
102
1.77
1.45
1.0
1.1
—
—
—
0
0
57
423
1.36
1.42
4.8
3.3
8650.96
1086.98
u/ml
0.47
46
360
33
221
1.50
1.41
3.2
3.2
0.83
0.83
nmol/l
0.03
23
175
31
205
1.52
1.41
1.1
1.1
—
—
—
0
0
11
53
2.08
1.38
1.2
1.3
—
—
—
0
0
13
67
1.95
1.38
1.7
1.2
9.31
12.19
u/l
0.53
13
58
37
256
1.46
1.36
1.1
1.1
0.67
1.64
u/ml
0.85
21
123
82
647
1.28
1.35
1.6
1.4
27.98
26.29
iu/l
0.18
74
550
41
291
1.42
1.33
1.1
1.1
0.66
2.70
u/ml
2.61
26
160
12
61
1.97
1.33
1.5
1.1
—
—
—
0
0
26
168
1.56
1.32
1.1
1.0
0.13
0.40
u/ml
0.82
12
50
6
24
2.51
1.30
2.0
1.3
—
—
—
0
0
9
43
2.10
1.30
1.8
1.3
—
—
—
0
0
22
138
1.60
1.26
1.1
1.1
—
—
—
0
0
47
346
1.37
1.25
2.2
1.9
5.83
5.29
iu/l
0.13
16
120
5
19
2.64
1.21
2.8
2.2
—
—
—
0
0
8
37
2.17
1.21
2.1
1.0
—
—
—
0
0
66
515
1.29
1.20
2.2
1.5
367.57
303.73
mu/l
0.60
61
462
29
197
1.48
1.19
1.3
1.2
3.54
5.40
u/ml
0.43
13
81
17
102
1.67
1.16
1.2
1.2
—
—
—
0
0
17
102
1.67
1.16
1.2
1.2
—
—
—
0
0
0
33
0.00
1.16
0.0
3.2
—
1.87
—
0
25
316
2867
1.13
1.13
5.3
5.1
2.83
3.16
ug/l
0.16
277
2546
22
145
1.52
1.06
1.1
1.1
—
—
—
0
0
10
179
0.56
1.05
1.0
1.4
6.75
7.49
mmol/l
—
10
156
59
464
1.28
1.04
1.5
1.4
—
—
—
0
0
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
9
47
1.92
1.02
1.7
1.7
—
—
—
0
0
55
431
1.29
1.01
1.7
1.7
—
—
—
0
0
34
248
1.38
1.00
1.1
1.1
6.14
1.90
u/ml
0.49
22
134
13
76
1.72
0.99
2.9
1.6
—
—
—
0
0
66
812
0.80
0.97
1.5
1.5
—
—
—
0
0
10
54
1.86
0.96
1.2
1.0
—
—
—
0
0
89
742
1.21
0.96
1.0
1.0
—
—
—
0
0
185
1642
1.14
0.95
2.1
2.1
—
—
—
0
0
112
956
1.19
0.95
1.3
1.2
85.15
141.88
iu/ml
1.92
41
372
93
1094
0.84
0.88
1.4
1.6
—
—
—
0
0
12
193
0.62
0.87
1.3
1.2
—
—
—
0
0
26
357
0.72
0.87
1.7
1.7
—
—
—
0
0
252
2295
1.12
0.87
4.3
4.4
21.70
21.49
%
0.07
131
1116
60
489
1.24
0.83
2.7
1.6
5.10
3.39
mg/l
1.08
48
359
25
181
1.39
0.80
1.3
1.1
—
—
—
0
0
251
2307
1.11
0.74
1.5
1.4
—
—
—
0
0
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
7
39
1.80
0.72
1.7
1.3
8.54
9.02
ug/l
—
7
39
341
3186
1.09
0.72
1.7
1.7
1.45
1.37
mmol/l
1.04
282
2692
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
37
461
0.80
0.66
1.4
1.5
—
—
—
0
0
5
28
1.79
0.66
1.0
1.0
63.68
42.07
u/ml
—
5
28
13
86
1.52
0.66
1.0
2.1
—
—
—
0
0
43
526
0.81
0.65
1.6
1.4
—
—
—
0
0
18
129
1.40
0.63
1.1
1.1
—
—
—
0
0
19
138
1.38
0.62
1.6
1.5
281.07
278.99
mosm/kgh2o
0.17
14
101
24
313
0.76
0.62
1.5
1.5
—
—
—
0
0
34
421
0.80
0.59
1.5
1.4
—
—
—
0
0
34
420
0.81
0.58
1.5
1.4
—
—
—
0
0
34
419
0.81
0.57
1.5
1.4
—
—
—
0
0
34
418
0.81
0.56
1.5
1.4
—
—
—
0
0
16
218
0.73
0.56
1.6
1.6
—
—
—
0
0
6
37
1.62
0.55
2.2
2.7
—
—
—
0
0
6
37
1.62
0.55
2.2
2.7
—
—
—
0
0
25
195
1.29
0.54
1.0
1.0
1.54
2.22
u/ml
—
9
86
9
61
1.48
0.53
1.2
1.2
158.43
167.64
pmol/l
—
9
61
180
1670
1.09
0.48
3.4
3.1
0.77
0.78
ug/l
0.07
131
1115
14
103
1.36
0.45
1.6
1.3
6.58
6.70
mmol/l
0.05
14
94
13
95
1.37
0.43
2.8
1.5
1.06
0.98
g/l
0.31
13
95
5
31
1.61
0.43
1.4
1.1
237.20
295.10
pmol/l
—
5
21
0
16
0.00
0.41
0.0
2.9
—
0.63
—
0
16
31
262
1.19
0.37
3.0
1.9
1.28
0.82
nmol/l
1.22
19
220
10
73
1.37
0.34
1.1
1.1
—
—
—
0
0
192
1817
1.06
0.33
2.3
2.2
—
—
—
0
0
22
261
0.84
0.30
3.6
3.4
21.53
25.36
mg/l
0.31
14
167
36
409
0.88
0.29
1.5
1.6
—
—
—
0
0
9
77
1.17
0.24
1.8
1.3
—
—
—
0
0
23
201
1.15
0.21
1.3
1.2
2.50
1.91
u/ml
—
8
64
8
101
0.79
0.21
1.4
1.6
—
—
—
0
0
9
83
1.08
0.14
1.3
1.5
—
—
—
0
0
9
83
1.08
0.14
1.6
1.5
—
—
—
0
0
23
209
1.10
0.13
1.3
1.2
—
—
—
0
0
15
134
1.12
0.11
1.3
1.1
95.87
94.93
%
0.05
15
126
15
135
1.11
0.09
1.0
1.1
—
—
—
0
0
21
227
0.92
0.09
1.7
1.7
—
—
—
0
0
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
7
68
1.03
0.07
2.4
1.7
0.29
4.83
u/field
—
7
51
24
225
1.07
0.07
1.5
1.5
0.23
0.32
nmol/l
0.76
16
179
9
84
1.07
0.07
1.3
1.4
81.67
79.48
umol/l
—
9
84
12
109
1.10
0.06
1.4
1.9
—
—
—
0
0
107
1088
0.98
0.04
1.9
1.9
—
—
—
0
0
44
453
0.97
0.04
1.5
1.4
—
—
—
0
0
48
490
0.98
0.02
1.5
1.9
—
—
—
0
0
88
871
1.01
0.01
1.8
1.8
—
—
—
0
0
22
214
1.03
0.00
2.1
2.3
10.78
6.06
umol/l
0.31
13
156
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
38.40
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
7.91
—
0
8
7
70
1.00
-0.00
7.4
12.4
585.57
831.31
nmol/l
—
7
65
0
5
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1766.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
-0.00
1.0
1.4
1.69
1.58
g/l
—
7
77
Mortality – FinRegistry
↥Association
Association between endpoint GENERALI_SKIN_ERUPT_DRUGS_MEDICAM and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| GENERALI_SKIN_ERUPT_DRUGS_MEDICAM | 1.819 [1.6, 2.07] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.29 |
During the follow-up period (1.1.1998 — 31.12.2019), 1245 out of 5640 females with GENERALI_SKIN_ERUPT_DRUGS_MEDICAM died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| GENERALI_SKIN_ERUPT_DRUGS_MEDICAM | 2.073 [1.77, 2.43] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 840 out of 3833 males with GENERALI_SKIN_ERUPT_DRUGS_MEDICAM died.
Mortality risk
Mortality risk for people of age
years, who have GENERALI_SKIN_ERUPT_DRUGS_MEDICAM.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.171% | 0.399% |
| 5 | 0.945% | 2.288% |
| 10 | 2.696% | 5.745% |
| 15 | 5.097% | 10.828% |
| 20 | 8.893% | 17.877% |
Relationships between endpoints
↥Index endpoint: GENERALI_SKIN_ERUPT_DRUGS_MEDICAM – Generalized skin eruption due to drugs and medicaments
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data